AbCellera Biologics Inc.
ABCL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $156 | $133 | $387 | $476 |
| Short-Term Investments | $469 | $627 | $500 | $247 |
| Receivables | $92 | $64 | $39 | $161 |
| Inventory | $0 | $1 | $2 | $2 |
| Other Curr. Assets | $34 | $46 | $99 | $45 |
| Total Curr. Assets | $751 | $872 | $1,025 | $930 |
| Property Plant & Equip (Net) | $340 | $288 | $217 | $112 |
| Goodwill | $48 | $48 | $48 | $48 |
| Intangibles | $42 | $120 | $132 | $148 |
| Long-Term Investments | $82 | $66 | $73 | $50 |
| Tax Assets | $0 | $0 | $5 | $7 |
| Other NC Assets | $97 | $94 | $41 | $23 |
| Total NC Assets | $609 | $616 | $515 | $389 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,361 | $1,488 | $1,541 | $1,319 |
| Liabilities | – | – | – | – |
| Payables | $34 | $26 | $15 | $15 |
| Short-Term Debt | $5 | $6 | $6 | $4 |
| Tax Payable | $0 | $0 | $0 | $36 |
| Deferred Revenue | $21 | $19 | $22 | $8 |
| Other Curr. Liab. | $16 | $68 | $76 | $59 |
| Total Curr. Liab. | $77 | $119 | $118 | $121 |
| LT Debt | $61 | $71 | $77 | $36 |
| Deferred Rev, NC | $156 | $104 | $60 | $61 |
| Deferred Tax Liab, NC | $10 | $31 | $33 | $37 |
| Other NC Liab. | $1 | $11 | $19 | $38 |
| Total NC Liab. | $228 | $217 | $189 | $172 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $65 | $77 | $82 | $40 |
| Total Liabilities | $304 | $336 | $308 | $293 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $777 | $753 | $734 | $722 |
| Retained Earnings | $117 | $280 | $426 | $268 |
| AOCI | -$4 | -$2 | -$1 | $0 |
| Other Equity | $166 | $121 | $74 | $35 |
| Total Equity | $1,056 | $1,152 | $1,233 | $1,026 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,361 | $1,488 | $1,541 | $1,319 |
| Net Debt | -$91 | -$56 | -$304 | -$436 |